{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:33Z","timestamp":1707524553081},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,23]]},"DOI":"10.7759\/cureus.25259","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T22:53:47Z","timestamp":1653346427000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of I127V Heterozygous Transthyretin Amyloidosis With Atypical Transthoracic Echocardiogram Findings Presenting As Upper Extremity Sensorimotor Polyneuropathy"],"prefix":"10.7759","author":[{"given":"Maja","family":"Ostojic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhraj S","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose David","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J","family":"Carry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S219979","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care","volume":"16","author":"Luigetti M","year":"2020","unstructured":"Luigetti M, Romano A, Di Paolantonio A, Bisogni G, Sabatelli M. Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag. 2020, 16:109-123. 10.2147\/TCRM.S219979","journal-title":"Ther Clin Risk Manag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1988696","article-title":"Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology","volume":"53","author":"Skrahina V","year":"2021","unstructured":"Skrahina V, Grittner U, Beetz C, et al.. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology. Ann Med. 2021, 53:1787-1796. 10.1080\/07853890.2021.1988696","journal-title":"Ann Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg FL","year":"2012","unstructured":"Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012, 126:1286-1300. 10.1161\/CIRCULATIONAHA.111.078915","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2015.1068949","article-title":"Evolving landscape in the management of transthyretin amyloidosis","volume":"47","author":"Hawkins PN","year":"2015","unstructured":"Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB. Evolving landscape in the management of transthyretin amyloidosis. Ann Med. 2015, 47:625-638. 10.3109\/07853890.2015.1068949","journal-title":"Ann Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180371","article-title":"Clinical presentation, diagnosis and treatment of TTR amyloidosis","volume":"6","author":"Kapoor M","year":"2019","unstructured":"Kapoor M, Rossor AM, Laura M, Reilly MM. Clinical presentation, diagnosis and treatment of TTR amyloidosis. J Neuromuscul Dis. 2019, 6:189-199. 10.3233\/JND-180371","journal-title":"J Neuromuscul Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-021-00626-4","article-title":"Amyloidosis with cardiac involvement: identification, characterization, and management","volume":"16","author":"Jamal F","year":"2021","unstructured":"Jamal F, Rosenzweig M. Amyloidosis with cardiac involvement: identification, characterization, and management. Curr Hematol Malig Rep. 2021, 16:357-366. 10.1007\/s11899-021-00626-4","journal-title":"Curr Hematol Malig Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan D","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P, et al.. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012, 98:1442-1448. 10.1136\/heartjnl-2012-302353","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11060996","article-title":"Nuclear imaging for the diagnosis of cardiac amyloidosis in 2021","volume":"11","author":"Li W","year":"2021","unstructured":"Li W, Uppal D, Wang YC, Xu X, Kokkinidis DG, Travin MI, Tauras JM. Nuclear imaging for the diagnosis of cardiac amyloidosis in 2021. Diagnostics (Basel). 2021, 11:996. 10.3390\/diagnostics11060996","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams D","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O'Riordan WD, et al.. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018, 379:11-21. 10.1056\/NEJMoa1716153","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-016-0040-x","article-title":"Mechanism of action and clinical application of tafamidis in hereditary transthyretin amyloidosis","volume":"5","author":"Coelho T","year":"2016","unstructured":"Coelho T, Merlini G, Bulawa CE, et al.. Mechanism of action and clinical application of tafamidis in hereditary transthyretin amyloidosis. Neurol Ther. 2016, 5:1-25. 10.1007\/s40120-016-0040-x","journal-title":"Neurol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/98393-a-rare-case-of-i127v-heterozygous-transthyretin-amyloidosis-with-atypical-transthoracic-echocardiogram-findings-presenting-as-upper-extremity-sensorimotor-polyneuropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:25Z","timestamp":1707507805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/98393-a-rare-case-of-i127v-heterozygous-transthyretin-amyloidosis-with-atypical-transthoracic-echocardiogram-findings-presenting-as-upper-extremity-sensorimotor-polyneuropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.25259","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,23]]}}}